INTERCEPT PHARMACEUTICALS, INC. short interest in 2018
In 2018, INTERCEPT PHARMACEUTICALS, INC.'s disclosed short interest ran from 21.65% of shares outstanding on 12 Jan 2018 to 10.23% on 31 Dec 2018, a change of -11.42 percentage points. The year's high was 27.87% on 29 Mar 2018 and its low 9.72% on 14 Dec 2018, averaging 17.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.80 days on 29 Mar 2018. Full history: INTERCEPT PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2018 in figures
- Start of year
- 21.65% (12 Jan 2018)
- End of year
- 10.23% (31 Dec 2018)
- Change
- -11.42 pp
- High
- 27.87% (29 Mar 2018)
- Low
- 9.72% (14 Dec 2018)
- Average
- 17.57%
- Highest days to cover
- 14.80 (29 Mar 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 21.65% | 5.73 | |
| 31 Jan 2018 | 21.96% | 5.47 | |
| 15 Feb 2018 | 26.90% | 5.00 | results (8-K) |
| 28 Feb 2018 | 27.28% | 12.31 | 10-K filed |
| 15 Mar 2018 | 27.47% | 10.60 | |
| 29 Mar 2018 | 27.87% | 14.80 | |
| 13 Apr 2018 | 23.49% | 4.11 | |
| 30 Apr 2018 | 19.73% | 7.64 | |
| 15 May 2018 | 20.07% | 11.90 | results (8-K), 10-Q filed |
| 31 May 2018 | 18.17% | 9.22 | |
| 15 Jun 2018 | 19.81% | 6.63 | |
| 29 Jun 2018 | 21.17% | 6.14 | |
| 13 Jul 2018 | 17.83% | 9.56 | |
| 31 Jul 2018 | 16.24% | 10.42 | |
| 15 Aug 2018 | 13.54% | 4.53 | results (8-K), 10-Q filed |
| 31 Aug 2018 | 12.79% | 13.00 | |
| 14 Sep 2018 | 12.44% | 12.02 | |
| 28 Sep 2018 | 11.26% | 7.19 | |
| 15 Oct 2018 | 10.46% | 6.03 | |
| 31 Oct 2018 | 10.41% | 5.91 | results (8-K) |
| 15 Nov 2018 | 10.71% | 6.52 | 10-Q filed |
| 30 Nov 2018 | 10.36% | 8.29 | |
| 14 Dec 2018 | 9.72% | 7.43 | |
| 31 Dec 2018 | 10.23% | 6.26 |
See also: INTERCEPT PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.